Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zymeworks
Biotech
ASCO: Jazz shares 'unprecedented' biliary tract cancer data
As zanidatamab awaits an FDA decision, Jazz is sharing long-term phase 2 data in advanced BTC for the HER2-targeted bispecific antibody.
Gabrielle Masson
Jun 1, 2024 11:11am
Zymeworks halts phase 2 ADC plans over 'clinical landscape'
Mar 7, 2024 9:00am
Jazz auditioning for new bandmates in hot M&A market
Jun 6, 2023 9:35am
Gilead taps Roche exec to fly Kite—Chutes & Ladders
May 19, 2023 9:30am
Zymeworks, Daiichi end $293M bispecific collab
Mar 20, 2023 9:15am
Zymeworks links HER2 bispecific to 84% survival at 18 months
Jan 19, 2023 9:55am
